Product Description
Overall, the global dental barrier membrane market was valued at $720 million in 2025. This is expected to increase over the forecast period at a CAGR of 7.9% to reach over $1.22 billion.
The full report suite on the global market for dental barrier membranes includes segments for resorbable and non-resorbable products, as well as segments for allografts, xenografts and synthetic barrier membrane products.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Dental Barrier Membrane Market Trends
The increasing clinical acceptance of dental membranes is expected to be an important driver of future market growth. At present, a notable proportion of dental professionals reserve membrane use for more complex cases, reflecting varying levels of familiarity with the full range of clinical benefits associated with guided bone and tissue regeneration. As the body of long-term clinical evidence continues to expand and demonstrates improved regenerative outcomes, enhanced implant success rates, and greater procedural predictability, the routine utilization of dental membranes is anticipated to rise. This shift in treatment protocols toward more standardized membrane use across a broader range of indications will support higher unit demand and contribute to sustained market expansion.
Global Dental Barrier Membrane Market Share Insights
- Geistlich led the global dental barrier membrane market in 2025. Its leading position was maintained by the workhorse Bio-Gide® collagen membrane product line. This portfolio consists of Bio-Gide® Perio, an extension of the Bio-Gide® product that maintains the same biological properties but is advertised as offering improved handling characteristics for periodontal procedures. Additionally, Geistlich strategically reinforces its market position by bundling its collagen membrane products with its Bio-Oss Collagen® xenograft product.
- ZimVie held the second-leading position in the global dental barrier membrane market in 2025, supported by its integrated regenerative biomaterials portfolio. Following the spin-off of Zimmer Biomet’s dental business in 2022, ZimVie continued to leverage its presence in dental implants and bone graft substitutes to support the adoption of its membrane products through cross-selling across complementary regenerative solutions. The company offers a diversified membrane portfolio that includes both resorbable and non-resorbable options used in guided bone regeneration procedures. Key products include the OsseoGuard® family of non-resorbable membranes, as well as resorbable collagen-based solutions such as BioMend®, BioMend® Extend, CopiOs® Extend and Puros® Pericardium Membrane, allowing clinicians to select products based on defect complexity and clinical preference. In 2025, ZimVie was acquired by ARCHIMED, transitioning the company from a publicly traded entity to a privately held organization. This acquisition is expected to support continued investment in ZimVie’s dental implant and regenerative biomaterials portfolio, including barrier membranes used in guided bone regeneration procedures.
- Henry Schein has strengthened its position as the third-largest global competitor in the dental bone graft substitutes market in 2025, driven primarily by the performance of its specialty brands, most notably BioHorizons and ACE Southern. BioHorizons continues to serve as the cornerstone of Henry Schein’s regenerative and implant-related portfolio, offering a comprehensive range of DBGS products, including MinerOss®, Grafton® DBM, and LADDEC®, which support a broad spectrum of grafting indications. The MinerOss® platform includes cortical, cancellous and composite allograft options, enabling BioHorizons to address both routine and complex clinical cases. While BioHorizons is often categorized as a mid-sized competitor relative to the largest pure-play biomaterials manufacturers, its consistent expansion across dental implant and regenerative product segments has significantly amplified Henry Schein’s global footprint. In parallel, ACE Southern has enhanced Henry Schein’s reach through its strong presence in surgical and grafting consumables, reinforcing distribution depth and brand visibility. Collectively, the performance of these subsidiary brands has been central to Henry Schein’s competitive positioning and sustained growth in the global dental bone graft substitutes market.
Global Dental Barrier Membrane Market Segmentation Summary
- Dental Barrier Membrane Market – Further Segmented Into:
- Type: Resorbable, and Non-Resorbable.
- Material: Xenografts, Synthetics, and Allografts.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Region | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
